These results indicate that CX3CL1‐CX3CR1 signaling is a molecular mechanism capable of modulating microglial‐mediated degeneration and represents a potential molecular target in therapeutic approaches to RP. The gene discussed is CX3CL1; the disease is retinitis pigmentosa 1.